SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-100506
Filing Date
2023-04-13
Accepted
2023-04-13 16:02:37
Documents
6
Effectiveness Date
2023-04-13

Document Format Files

Seq Description Document Type Size
1 S-8 d471860ds8.htm S-8 58019
2 EX-5.1 d471860dex51.htm EX-5.1 8328
3 EX-23.1 d471860dex231.htm EX-23.1 1491
4 EX-99.1 d471860dex991.htm EX-99.1 236183
5 EX-FILING FEES d471860dexfilingfees.htm EX-FILING FEES 14470
6 GRAPHIC g471860dsp1.jpg GRAPHIC 17121
  Complete submission text file 0001193125-23-100506.txt   343279
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271237 | Film No.: 23818360
SIC: 2834 Pharmaceutical Preparations